# Elena Vasquez, PhD

## Experience

**Sanofi** | Senior Biostatistician | 2021–Present

- Spearheaded the design and implementation of adaptive enrichment strategies for Phase III oncology trials
- Spearheaded development of a comprehensive Bayesian subgroup analysis R package
- Leveraged cutting-edge statistical methodologies to optimize group sequential monitoring frameworks
- Championed the adoption of the estimand framework across multiple therapeutic areas
- Championed cross-functional collaboration to enhance clinical trial efficiency

Moreover, the team achieved significant improvements in trial operations. Furthermore, these innovations led to substantial cost savings across the department.

**Dana-Farber Cancer Institute** | Biostatistician II | 2018–2021

- Spearheaded novel Bayesian dose-optimization research published in Statistics in Medicine
- Leveraged advanced statistical techniques to contribute to NIH R01 grant applications
- Championed the development of automated reporting pipelines for clinical data

Additionally, the research team expanded its capabilities in immuno-oncology analytics.

## Education

PhD Biostatistics, Harvard T.H. Chan School of Public Health, 2018
MS Statistics, University of Michigan, 2014

## Publications

- Published research on adaptive enrichment, Bayesian optimization, and competing risks analysis

## Skills

- Expert in R, SAS, and Python for statistical modeling, data analysis, and clinical trial design
- Proficient in Bayesian methods, survival analysis, and causal inference
- Skilled in adaptive trial design, group sequential methods, and mixed effects models
